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350a Monday, February 22, 2010Native frog Tm was cross-linked with DTNB at Cys 190. Tryptic cleavage
patterns of this cross-linked species were compared to a control Tm in which
the Cys 190 groups were maintained reduced state using DTT. The course of
tryptic cleavage of the cross-linked molecule was altered compared to the fully
reduced molecule. Proteolysis of the cross-linked molecule produced new
tryptic fragments seen in a reduced SDS gel at 30kDa and 20kDa. Trypsin
cleaves reduced tropomyosin at Arg 133 to produce two new tryptic fragments
(17kDa and 15kDa). The observation that cross-linked Tm exhibits a change
in the cleavage rate, and affects the cleavage pattern, demonstrates a long-range
effect of the cross-link at Cys 190 on the site of trypsin cleavage, Arg 133.
This finding adds evidence to the idea that ‘‘flexibility’’ is associated with a lo-
cally fluctuating region in the middle of the molecule which has implications on
our understanding of how Tm moves on the actin surface, and provides insight
into understanding how single point mutations in Tm may result in dysfunction
and disease associated with various myopathies.
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Tropomyosin contains a phosphorylation site at Ser-283 located within the
head-to-tail overlap region that regulates muscle contraction. Previously we
demonstrated that recombinant wild-type (Tm-WT) and pseudo-phosphory-
lated (Tm-S283D) alpha tropomyosin, expressed and purified from insect
cells, exhibit regulated ATPase activity and troponin T binding similar to
that reported for non-phosphorylated and phosphorylated tropomyosin
(pTm) purified from muscle. We further demonstrated transgenic mice ex-
pressing the pseudo-phosphorylated tropomyosin (Tm-S283D Tg) exhibit in-
creased mortality and decreased rate of relaxation in the work performing
heart preparation. These changes occur in the absence of altered steady state
maximal force or calcium-sensitive force development in skinned papillary
bundles. In light of these findings, we sought to investigate the effect of
pTm on the kinetics of cardiac muscle function. Using an extraction/replace-
ment protocol, we measured force kinetics in a myofibril preparation. Results
demonstrate no significant difference between myofibrils replaced with Tm-
S283D or Tm-WT in maximal force, the rate of force activation, or the rate
of force redevelopment, implying pTm does not play a role in altering muscle
activation or cycling kinetics. To investigate if pTm affects the kinetics of thin
filament inactivation we measured the rate of calcium disassociation from tro-
ponin C. Results demonstrate thin filaments reconstituted with Tm-S283D de-
creased the rate of calcium disassociation from troponin C consistent with the
previously observed relaxation impairment. Finally, to determine the effects
of pTm on systemic alterations in cardiovascular performance we measured
heart function in Tm-S283D Tg mice by echocardiography. Results demon-
strate Tm-S283D Tg mice exhibit trends towards impaired cardiac contractil-
ity compared to non-transgenic mice including decreased peak systolic veloc-
ity and ejection fraction. Overall, these findings demonstrate tropomyosin
phosphorylation contributes to the regulation of cardiac dynamics; however,
the precise role of pTm in the development of cardiac dysfunction remains
elusive.
1815-Pos
Studies of the Mid Region of Tropomyosin Using an Incorporated Trypto-
phan Analogue
Julie J. Mouannes, Tomoyoshi Kobayashi, Daniel Leek, Larry Tobacman.
University of Illinois at Chicago, Chicago, IL, USA.
Striated muscle contraction is controlled by highly sensitive alterations in thin
filament conformation that involve a Ca2þ-dependent interaction between tro-
ponin I (TnI) and actin-tropomyosin (Tm). To study these interactions, 5-OH
Tryptophan (OHW) was incorporated into striated muscle alpha-tropomyosin.
A Single Trp tropomyosin mutant, Q135W, was generated and expressed in Trp
auxotrophs. OHW incorporation was 76%. Thin filaments containing Q135W
retained excellent function: 12-fold Ca2þ regulation in myosin S1-thin fila-
ment MgATPase assays. Fluorescence emission titrations with increasing
amounts of Ca2þ were performed (emission max 338nm) in presence of thin
filaments comprised of cardiac troponin, F-actin, and Q135W tropomyosin.
Similar titrations using troponin, actin, and wt Trp-free tropomyosin produced
low fluorescence (ex wavelength 312 nm). Ca2þ decreased the OHW fluores-
cence of Q135W-containing thin filaments by 7.0 þ/ 0.4 %. This transition
occurred with K ¼ 1.8 þ/ 0.3 uM 1, consistent with the affinity of the car-diac thin filament regulatory calcium site on TnC. OHW Q135W tropomyosin
is a novel tool for monitoring thin filament behavior, in particular for detecting
Ca2þ binding to troponin. Troponin has been viewed as binding to the C-ter-
minus of tropomyosin, which does not include the mid-tropomyosin residue
135 that is found in the current study to be Ca2þ-sensitive. However, the find-
ings may be related to recent results, suggesting that the TnI C-terminus of tro-
ponin bridges from one actin strand to the other, and contacts tropomyosin near
residue 146. Galinska-Rakoczy et al, JMB 2008. Mudalige et al, JMB2009.
Finally, human cardiac troponins with defective inhibitory activity due to alter-
ations in the TnI inhibitory region have been generated. They are currently un-
der study using this tropomyosin.
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Nemaline myopathy (NM) and cap disease (CD) are two congenital skeletal
muscle myopathies characterized by general muscle weakness with early neo-
natal onset. They are both clinically and genetically heterogeneous, but at the
histological level they present characteristic pathology: nemaline rod-like bod-
ies within myofibers generating from the Z-discs for NM and cap-like struc-
tures at cell periphery underneath the sarcolemma for CD. Recently several dif-
ferent mutations on the TPM2 gene, coding for the -tropomyosin (-Tm) isoform
expressed in skeletal muscles (especially slow-twitch type 1 fibers), have been
reported to cause either NM or CD. In this study six -Tm mutants connected
either to NM (K7, E117K, Q147P) or to CD (E41K, K49, E139) and the
wild type form have been expressed in a baculovirus/sf9 system. This system,
being based on eukaryotic cell cultures, permits the N-terminal acetylation of
-Tm, which has been shown to be important for its linear head-to-tail polymer-
isation. Thin filaments reconstituted with these recombinant proteins have been
tested with the in vitromotility assay finding a considerable loss of function for
each of them. K7, Q147P, K49 and E139 showed, through indirect observa-
tions, a reduced affinity to actin, possibly explained by destabilising the Tm ho-
modimer itself or important actin-Tm binding sites. With all mutants the Ca2þ-
induced increase in sliding speed was greatly reduced, indicating an altered
TroponinT-Tm interaction, but thin filaments Ca2þ switching was unaltered.
The three NM mutants showed a reduced Ca2þ-sensitivity, whereas two of
the CD mutants showed an increase. E41K had a different phenotype and
seemed to strongly inhibit filament motility. A well-defined scenario is taking
shape and further studies could directly correlate these findings with the etiol-
ogy of the diseases.
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Tropomyosin is a two-chained, a-helical coiled-coil protein that associates end-
to-end to form a continuous strand along actin filaments and regulates the func-
tions and stability of actin. Mutations in tropomyosin cause skeletal and cardio-
myopathies. We have carried out a phylogenetic analysis of tropomyosin to
identify its conserved residues and to elucidate their importance for binding ac-
tin. Actin is a highly conserved protein and our hypothesis is that the actin bind-
ing sites of tropomyosin have been conserved through evolution to retain its ac-
tin-binding function. Phylogenetic trees of 60 coding sequences were
constructed from tropomyosin genes from 19 species within the phyla Chor-
data, Hemichordata and Echinoderm. The rates of substitution (u) at amino
acid sites (codons) in the protein sequence were calculated to identify the
most conserved sites (lowest u) using CODEML in PAML 4.1. A total of
103 out of 284 residues were identified as highly conserved (u % 0.015), of
which 24 are in a and d positions of the heptad repeat involved in the hydropho-
bic coiled coil interface, 38 are in potential interhelical e-g position salt bridges
important for folding of the coiled coil, and 41 are in b, c, or f surface positions
available for binding to other proteins, such as actin. The conserved residues at
the b, c, and f surface positions were selected for initial mutagenesis studies
with mutations to alanine. Preliminary actin binding co-sedimentation assays
carried out for three tropomyosin mutants showed a 2- to 3-fold decrease in ac-
tin-binding affinity compared to the wild-type protein. Further analysis of mu-
tations at other conserved surface positions and their effect on actin-binding af-
finity and stability of the mutant proteins are in progress. Supported by Muscle
Dystrophy Association.
